A New Treatment Strategy in Basal Ganglia Hemorrhage for Moyamoya Disease: A Retrospective Study

Bingzheng He#, Lei Cao#, Yang Dong, Jing Wang, Xianzhi Liu, Bo Yang* and Hongwei Li*

Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, China
#These authors contributed equally to this work

^*Correspondance to: Hongwei Li 

 PDF  Full Text DOI: 10.25107/2474-1647.2809

Abstract

Objective: To analyze the clinical characteristics and explore the surgical treatment strategies of basal ganglia hemorrhage patients with moyamoya disease. Methods: Follow-up data of all patients were obtained in this retrospective study, and SPSS 21 was used to analysis the statistical significance. Results: A total of 78 patients (38 males and 40 females) were enrolled, the average age was 43.7 years ± 11.5 years, and the median time from onset to hospitalization was 3 h. Clinically, there were 47 cases mainly presented with dizziness and headache, 19 cases only presented with limb movement disorder and/or language disorder, 12 cases presented with sudden loss of consciousness and 2 cases with epilepsy. Logistic regression analysis showed that hemorrhage broke into the ventricle (OR=12.382, P=0.021

Keywords

Basal ganglia hemorrhage; Moyamoya disease; Clinical features; Surgical strategy

Cite the article

He B, Cao L, Dong Y, Wang J, Liu X, Yang B, et al. A New Treatment Strategy in Basal Ganglia Hemorrhage for Moyamoya Disease: A Retrospective Study. Clin Surg. 2020; 5: 2809.